Rhea-AI Summary
Micro Imaging Technology (OTC: MMTC) announced the acquisition of Cellmyx, a provider of aesthetic, cosmetic surgery and regenerative medicine tools. The deal complements the late-2025 acquisition of SaltMed/SaltFacial and is intended to support national and global product expansion.
Cellmyx focuses on autologous adipose grafting and transfer technologies for orthopedic, pain management and regenerative medicine. Its intelliFat BOD device received FDA 510(k) clearance in early 2023 for use in orthopedic, plastic and cosmetic surgery procedures using a patient’s own adipose tissue.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
FAQ
What is the current stock price of MICRO IMAGING TECH (MMTC)?
MICRO IMAGING TECH (MMTC) last closed at $0.000101.
What is the market cap of MICRO IMAGING TECH (MMTC)?
The market cap of MICRO IMAGING TECH (MMTC) is approximately $910.0.